Guilin Qiao, PhD
Associate Professor
Surgery
School of Medicine

Publications (8)

Top publication keywords:
Interleukin-2CD3 ComplexRose BengalT-LymphocytesColonic NeoplasmsLymphocytes, Tumor-InfiltratingTumor Necrosis Factor Ligand Superfamily Member 14Cancer VaccinesThyroid Carcinoma, AnaplasticTNF-Related Apoptosis-Inducing LigandImmunotherapyDeath Domain Receptor Signaling Adaptor ProteinsMitoxantroneGuanine Nucleotide Exchange FactorsAntibodies, Bispecific

• Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
  Cancers 2023 Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B
• LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
  Oncogene 2022 Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV
• Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
  The Journal of surgical research 2021 Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV
• MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
  Endocrine-related cancer 2019 Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS
• Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
  The Journal of surgical research 2018 Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV
• LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
  Cancer research 2017 Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV
• Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
  Cell death & disease 2017 Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV
• Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis.
  Cell death discovery 2016 Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV